Related Experiment Video

Updated: Jun 13, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pseudomonas aeruginosa and the host pulmonary immune response

Patricia J Dubin1, Jay K Kolls

  • 1Children's Hospital of Pittsburgh, Suite 3765, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA. patricia.dubin@chp.edu

Expert Review of Respiratory Medicine
|May 19, 2010
PubMed

Insights

Pseudomonas aeruginosa is an adaptable pathogen causing infections, particularly in cystic fibrosis (CF). Its rapid adaptation and resistance underscore the need for novel immunotherapies targeting both the pathogen and host immune responses.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonary Medicine

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen prevalent in the environment.
  • It causes acute and chronic infections, with host factors influencing disease severity.
  • P. aeruginosa is extensively studied in cystic fibrosis (CF) due to its adaptability to the CF airway.

Purpose of the Study:

  • To explore the adaptability of P. aeruginosa in the context of chronic infections.
  • To highlight the development of virulence factors and antimicrobial resistance by P. aeruginosa.
  • To emphasize the growing importance of immunotherapies for P. aeruginosa infections, especially in CF.

Main Methods:

  • The study reviews the adaptability and virulence of P. aeruginosa.
  • It examines the transition from colonization to chronic infection in CF airways.
  • Antimicrobial resistance development and host immune interactions are analyzed.

Main Results:

  • P. aeruginosa rapidly adapts to the CF lung environment.
  • The pathogen expresses virulence factors and develops antimicrobial resistance.
  • Chronic infection leads to progressive lung damage in CF patients.

Conclusions:

  • The adaptability and resistance of P. aeruginosa pose significant challenges in CF care.
  • Host- and organism-targeted immunotherapies are crucial for managing chronic P. aeruginosa infections.
  • Further research into immunotherapies is warranted given increased longevity in CF individuals.

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...